HArmonyCa is a hybrid injectable product with dual effect. The new filler contains two active ingredients, calcium hydroxyapatite (CaHa) and hyaluronic acid (HA). HArmonyCa with lidocaine has the ability to improve skin quality and counteract the signs of ageing through an immediate lifting effect provided by hyaluronic acid and a sustained lifting effect provided by collagen production stimulated by calcium hydroxyapatite.
AbbVie Group's Allergan Aesthetics presented its new aesthetic medicine treatment in Milan, announcing its entry into the hybrid injectable filler category with an ad-hoc treatment capable of reducing the signs of ageing on the face in a multidimensional way thanks to the two active ingredients it contains.
"With the launch of HarmonyCa, Allergan Aesthetics confirms its concrete commitment to strengthen and lead innovation in the aesthetic medicine sector with this absolute novelty in the hybrid injectable filler category."
"This new treatment allows us to diversify our portfolio and thus respond to different patient needs. Our goal is to support patients to gain more and more confidence in aesthetic medicine as a branch of medicine and as a solution to their needs."
Skinmed Clinic is one of the first dermatology and aesthetic centres in Romania to take advantage of this new treatment:
"We know well that skin texture changes over time, which is why a multidimensional approach is needed. In addition, tissue laxity and sagging/ sagging skin can accentuate the need for this approach. Thanks to this new injectable, which combines the dual action of hyaluronic acid and calcium hydroxyapatite, an immediate and prolonged lifting effect is guaranteed, with a consequent improvement in facial features. The combination of the two substances in a single solution is a new option for both patients and experienced medical specialists."
How hyaluronic acid (HA) works and calcium hydroxyapatite (CaHa)?
Hyaluronic acid particles penetrate deep into the skin, where they exert a plumping and volumising action for an immediate lifting effect. In addition, calcium hydroxyapatite particles support the body's production of collagen, so new collagen fibres begin to form. As the gel gradually disappears, a firm and dense network of collagen appears in its place for a gradual and long-lasting lifting effect associated with calcium hydroxyapatite. During your consultation, your doctor will explain how HArmonyCa works and answer any questions you may have.
What the procedure involves and which areas of the face can be treated with HArmonyCa?
First, your doctor will discuss your concerns, assess whether HArmonyCa treatment is right for you and suggest which areas of your face can be treated with HArmonyCa. Then, he or she will administer HArmonyCa injections to the areas that need treatment. HArmonyCa contains lidocaine, an anaesthetic that is designed to reduce discomfort during treatment.
HArmonyCa can be used in the deep dermal layer in certain areas of the face, but cannot be injected around the eyes, in the lips or in the perioral area.
What are the indications before and after treatment with HArmonyCa?
During the consultation, your doctor will tell you what you should do before and after treatment with HArmonyCa. It is good to know that after treatment, you should:
- Avoid exercise or high-intensity activities, sun exposure, tanning equipment or extreme weather conditions for 24 hours;
- Apply ice or cold compresses to treated areas for 24 hours, as most injectable treatments can cause redness, swelling and irritation;
- Massage the treated areas if you feel small lumps.
HArmonyCa injection results and their duration
HArmonyCa provides an immediate lifting effect while stimulating collagen production. Research indicates that HArmonyCa provides an immediate lifting effect starting as early as two weeks after injection, and results have been demonstrated in 86% of the 85 areas treated. In fact, 92% of patients treated with HArmonyCa reported an improvement in the overall appearance of treated facial areas.
A survey of patients treated with HArmonyCa shows that the majority of patients were very satisfied with the treatment (average score of 4.1 out of 5) after 19 months.
